AstraZeneca (AZNCF) News Today $133.40 +1.70 (+1.29%) (As of 12/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartDividendFinancialsHeadlinesOwnershipSEC FilingsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period AstraZeneca lacks good medicine for Chinese limboDecember 13, 2024 | reuters.comAstraZeneca (AZN) Gets a Hold from Kepler CapitalDecember 13, 2024 | markets.businessinsider.comAstraZeneca, Daiichi Sankyo announce BTD for datopotamab deruxtecanDecember 9, 2024 | markets.businessinsider.comJ.P. Morgan Keeps Their Buy Rating on AstraZeneca (AZN)December 9, 2024 | markets.businessinsider.comAstraZeneca granted priority review for Imfinzi sBLADecember 6, 2024 | markets.businessinsider.comDrugmaker AstraZeneca names new China chief to replace detained executiveDecember 6, 2024 | msn.comAZN : TROPION Analysis Reveals Datopotamab Deruxtecan Efficacy In Advanced EGFR-Mutated Lung CancerDecember 6, 2024 | markets.businessinsider.comJ.P. Morgan Sticks to Its Buy Rating for AstraZeneca (AZN)December 3, 2024 | markets.businessinsider.comPharma Stock Roundup: RHHBY to Buy PSTX, MRK, AZN See Pipeline SuccessNovember 29, 2024 | msn.comGCAR and AstraZeneca execute agreement to evaluate AZD1390 for glioblastomaNovember 25, 2024 | msn.comAstraZeneca Names A MSK Leader To Global Cancer PostNovember 25, 2024 | forbes.comAstraZeneca PLC ADR underperforms Wednesday when compared to competitorsNovember 20, 2024 | msn.comAstraZeneca Director Invests in Company SharesNovember 20, 2024 | markets.businessinsider.comAstraZeneca shares trade higher on UBS UpgradeNovember 20, 2024 | in.investing.comAstraZeneca raised to neutral at UBS despite China headwindsNovember 20, 2024 | msn.comAstraZeneca upgraded to Neutral from Sell at UBSNovember 20, 2024 | markets.businessinsider.comAstraZeneca price target lowered to EUR 140 from EUR 150 at BerenbergNovember 20, 2024 | markets.businessinsider.comAstraZeneca Loses Lone Bear as UBS Upgrades After China-Led RoutNovember 20, 2024 | bloomberg.comAstraZeneca picks first Treg cell therapy from Quell Therapeutics partnershipNovember 18, 2024 | finance.yahoo.comTOP NEWS: AstraZeneca hails recommended EU approval of TagrissoNovember 18, 2024 | lse.co.ukAstraZeneca’s Tagrisso Gains EU Approval NodNovember 18, 2024 | markets.businessinsider.comAstraZeneca buildings for sale in FairfaxNovember 17, 2024 | warriorswire.usatoday.comAstraZeneca Director Bolsters Stake with Share PurchaseNovember 14, 2024 | markets.businessinsider.comAstraZeneca: Strong Q3 Growth and Strategic Moves Justify Buy RatingNovember 14, 2024 | markets.businessinsider.comAstraZeneca’s Koselugo Expands Potential in Adult TreatmentNovember 13, 2024 | markets.businessinsider.comMerck and AstraZeneca announce results of Koselugo in neurofibromatosis trialNovember 12, 2024 | markets.businessinsider.comAstraZeneca Lifts 2024 Forecast On Better Than Expected Q3 Performance, Says It Takes China Investigations 'Very Seriously'November 12, 2024 | finance.yahoo.comAstraZeneca to fully cooperate with Chinese authorities if requestedNovember 12, 2024 | markets.businessinsider.comAstraZeneca Q3 Earnings Preview: Will Cancer, Heart Drugs Fuel Continued Growth?November 11, 2024 | benzinga.comPharma Giant AstraZeneca Says China Chief DetainedNovember 8, 2024 | barrons.comAstraZeneca (AZN) Gets a Sell from Deutsche BankNovember 5, 2024 | markets.businessinsider.comAstraZeneca’s Promising Obesity Treatment Advances Justify Buy Rating: Analyst ReportNovember 5, 2024 | markets.businessinsider.comAstraZeneca fraud investigation expands in ChinaNovember 5, 2024 | msn.comAstraZeneca's Obesity Pills Revealed Positive Result In Phase I TrialsNovember 5, 2024 | finance.yahoo.comPharma giant AstraZeneca says its China chief is under investigationNovember 1, 2024 | msn.comAstraZeneca Announces Share Capital DetailsNovember 1, 2024 | markets.businessinsider.comPharma Giant AstraZeneca Says China Chief Under InvestigationOctober 31, 2024 | barrons.comFirstFT: AstraZeneca China president under investigationOctober 30, 2024 | ft.comAstraZeneca pleased as EU approves Fasenra for treatment of EGPAOctober 29, 2024 | lse.co.ukJ.P. Morgan Remains a Buy on AstraZeneca (AZN)October 26, 2024 | markets.businessinsider.comChina Detains Ex-AstraZeneca Executive in Sign of Widening ProbeOctober 25, 2024 | bloomberg.comAstraZeneca polyneuropathy treatment recommended for EU approvalOctober 21, 2024 | lse.co.ukAs AstraZeneca’s share price drops 11%, does the stock look an unmissable bargain to me?October 21, 2024 | fool.co.ukAstraZeneca remains steady Thursday, underperforms marketOctober 17, 2024 | marketwatch.comIs AstraZeneca PLC (AZN) the Best High Growth NASDAQ Stock That is Profitable in 2024?October 16, 2024 | insidermonkey.comAstraZeneca’s Phase III trial of treatment for asthma meets its primary endpointOctober 8, 2024 | finance.yahoo.comOwkin partners with AstraZeneca to enhance gBRCA testing for breast cancerOctober 4, 2024 | msn.comOwkin and AstraZeneca to develop AI tool for breast cancer testingOctober 3, 2024 | finance.yahoo.comAstraZeneca (AZN): A Strong Buy as FDA Approves Key Cancer Treatments and Revenue SurgesSeptember 30, 2024 | msn.comImmunai, AstraZeneca collaborate to optimize cancer clinical trialsSeptember 26, 2024 | msn.com Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZNCF and its competitors with MarketBeat's FREE daily newsletter. Email Address This drone stock is setting up to transform medical supply delivery (Ad)Drone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks. Click here to see how a new partnership could catapult this drone suppliers' growth AZNCF Media Mentions By Week AZNCF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZNCF News Sentiment▼0.260.65▲Average Medical News Sentiment AZNCF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZNCF Articles This Week▼36▲AZNCF Articles Average Week Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZNCF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 4Front Ventures News Today Algernon Pharmaceuticals News Today Allstar Health Brands News Today Alvotech News Today American Premium Mining News Today Anew Medical News Today Arno Therapeutics News Today AVVAA World Health Care Products News Today Basilea Pharmaceutica News Today biote News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:AZNCF) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AZNCF Stock Alerts